Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 6
Treatment-assignment count: 0
Stratification count: 0
Cdx Established Context
PD-L1 expression
breast cancer · Small Molecule Inhibitor
PD-L1 expression is flagged as cdx established context because public trials show inclusion required evidence in 12 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 0
Common snippets: None extracted
Threshold label: Low
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 1
Recent signals: 1
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT05082259 | https://clinicaltrials.gov/study/NCT05422794 | https://clinicaltrials.gov/study/NCT05749575 | https://clinicaltrials.gov/study/NCT04684459 | https://clinicaltrials.gov/study/NCT03952325 | https://clinicaltrials.gov/study/NCT07401537 | https://clinicaltrials.gov/study/NCT06471673 | https://clinicaltrials.gov/study/NCT02685059 | https://clinicaltrials.gov/study/NCT03911453 | https://clinicaltrials.gov/study/NCT03775850 | https://clinicaltrials.gov/study/NCT03894007 | https://clinicaltrials.gov/study/NCT04759248